the Effect of Dexmedetomidine and Licodaine on Acute Postoperative Pain in Gynecological Laparoscopy
NCT ID: NCT04906889
Last Updated: 2023-01-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
NA
INTERVENTIONAL
2021-06-01
2022-06-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
the Effect of Opioid-free General Anesthesia
NCT04409964
Opioid Sparing Anaesthesia for Prevention of Postoperative Nausea and Vomiting in Laparoscopic Gynecological Surgery
NCT04706897
Effect of Multimodal Opioid-free Anesthesia on Return of Bowel Function in Laparoscopic Colorectal Surgery
NCT04144933
Effect of Lidocaine Plus Dexmedetomidine Infusion on PONV
NCT03788018
Dexmedetomidine Combined With Lidocaine Infusion Affect PONV
NCT03809923
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
dexmedetomidine-lidocaine
The study group receives the dexmedetomidine and lidocaine infusion with general anesthesia for gynecological laparoscopy.
Dexmedetomidine Hydrochloride
dexmedetomidine iv bolus for 10 minutes followed by the infusion of 0.1-1 ug/kg/h during general anesthesia
Lidocaine Hydrochloride
lidocaine iv bolus followed by the infusion of 1.5mg/kg/h during general anesthesia
remifentanil
The control group receives the remifentanil infusion with general anesthesia for gynecological laparoscopy
Remifentanil Hydrochloride
remifentanil iv infusion of 0.5-5 ng/ml (effect site concentration using TCI) during general anesthesia
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Dexmedetomidine Hydrochloride
dexmedetomidine iv bolus for 10 minutes followed by the infusion of 0.1-1 ug/kg/h during general anesthesia
Remifentanil Hydrochloride
remifentanil iv infusion of 0.5-5 ng/ml (effect site concentration using TCI) during general anesthesia
Lidocaine Hydrochloride
lidocaine iv bolus followed by the infusion of 1.5mg/kg/h during general anesthesia
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* cancer surgery
* chronic pain requiring pain killers
* psychiatric disease
* preoperative bradycardia (HR \< 50 bpm)
* allergies
* pregnancy or breast feeding
20 Years
70 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
The Catholic University of Korea
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Young Eun Moon
Associate professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Young Eun Moon, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Associate professor, Department of Anesthesiology and Pain Medicine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Seoul St.Mary's Hospital
Seoul, Seocho-gu, South Korea
Seoul St.Mary's Hospital
Seocho, , South Korea
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
dexmedetomidine-lidocaine
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.